The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection.
Lai P, Chen X, Qin L, Jiang Z, Luo C, Huang X, Wu S, Ling W, Wang Y, Wang J, Deng C, Huang L, Zeng L, Lu Z, Zhong L, Liao P, Li M, Chen D, Geng S, Wu P, Tang Z, Pei D, Du X, Li P, Weng J.
Lai P, et al. Among authors: qin l.
Leukemia. 2020 Oct;34(10):2790-2793. doi: 10.1038/s41375-020-0952-4. Epub 2020 Jul 6.
Leukemia. 2020.
PMID: 32632097
No abstract available.